Sundance Strategies (SUND) 10-Q 9 Aug 16 2017 Q1 Quarterly report Financial data

DOCUMENT AND ENTITY INFORMATION

DOCUMENT AND ENTITY INFORMATION - shares	3 Months Ended
	Jun. 30, 2016	Aug. 09, 2016
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2016
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q1
Entity Registrant Name	Sundance Strategies, Inc.
Entity Central Index Key	1,171,838
Current Fiscal Year End Date	--03-31
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		44,128,441

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2016	Mar. 31, 2016
Current Assets
Cash and Cash Equivalents	$ 6,254	$ 24,717
Prepaid Expenses	10,000	1,875
Total Current Assets	16,254	26,592
Long-Term Assets
Investment in Net Insurance Benefits	29,858,188	29,822,186
Other	2,204
Total Long-term Assets	29,860,392	29,822,186
Total Assets	29,876,646	29,848,778
Current Liabilities
Accounts Payable	389,936	351,671
Manditorily Redeemable Common Stock		750,000
Total Current Liabilities	389,936	1,101,671
Long-Term Liabilities
Note Payable-Related Party	3,875,178	3,820,178
Convertible Debenture	700,000	700,000
Accrued Expenses	132,370	192,157
Total Long-Term Liabilities	4,707,548	4,712,335
Total Liabilities	5,097,484	5,814,006
Commitments and contingencies
Stockholders' Equity
Preferred Stock, authorized 10,000,000 shares, par value $0.001; -0- shares issued and outstanding
Common Stock, authorized 500,000,000 shares, par value $0.001; 44,128,441 and 44,128,441 shares issued and outstanding, respectively	44,129	44,129
Additional Paid In Capital	24,468,286	24,364,442
Retained Earnings (Accumulated Deficit)	266,748	(373,799)
Total Stockholders' Equity	24,779,162	24,034,772
Total Liabilities and Stockholders' Equity	$ 29,876,646	$ 29,848,778

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2016	Mar. 31, 2016
Statement of Financial Position [Abstract]
Preferred Stock, shares authorized	10,000,000	10,000,000
Preferred Stock, par value per share	$ 0.001	$ 0.001
Preferred Stock, shares issued	0	0
Preferred Stock, shares outstanding	0	0
Common Stock, shares authorized	500,000,000	500,000,000
Common Stock, par value per share	$ 0.001	$ 0.001
Common Stock, shares issued	44,128,441	44,128,441
Common Stock, shares outstanding	44,128,441	44,128,441

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Income Statement [Abstract]
Interest Income on Investment in Net Insurance Benefits	$ 1,453,872	$ 824,030
General and Administrative Expenses	727,443	595,954
Income from Operations	726,429	228,076
Other Income (Expense)
Interest Income		4,702
Interest Expense	(85,882)	(39,202)
Total Other Expense	(85,882)	(34,500)
Income Before Income Taxes	640,547	193,576
Income Tax Provision
Net Income	$ 640,547	$ 193,576
Basic and Diluted:
Basic Earnings Per Share	$ 0.01
Fully Diluted Earnings Per Share	$ 0.01
Basic Weighted Average Number of Shares Outstanding	44,140,669	43,433,750
Fully Diluted Weighted Average Number of Shares Outstanding	45,482,299	44,826,040

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Operating Activities
Net Income	$ 640,547	$ 193,576
Adjustments to reconcile to cash from operating activities:
Share Based Compensation - Options	103,843	98,317
Accrued Interest on NIBs	(1,453,872)	(824,030)
Cash Received on Accrued Interest Income on NIBs	1,417,870
Advance for Investments in Net Insurance Benefits		(237,647)
Changes in Operating Assets and Liabilities
Accrued Interest Income	(2,204)	(11,447)
Prepaid Expenses	(8,125)	1,875
Accounts Payable	38,265	93,990
Accrued Expenses	(59,787)	45,947
Net Cash from Operating Activities	676,537	(639,419)
Financing Activities
Proceeds from Issuance of Notes Payable and Lines-of-Credit, Related Party	205,000	375,000
Repayment of Notes Payable and Lines-of-Credit, Related Party	(150,000)
Proceeds from Issuance of Convertible Debenture		700,000
Redemption of Temporary Equity		(750,000)
Redemption of Mandatorily Redeemable Common Stock	(750,000)
Net Cash from Financing Activities	(695,000)	325,000
Net Change in Cash	(18,463)	(314,419)
Cash at Beginning of Period	24,717	336,370
Cash at End of Period	6,254	21,951
Non Cash Financing & Investing Activities
Exchange Note Payable and Accrued Interest for Temporary Equity		$ 1,500,000

ORGANIZATION AND BASIS OF PRESE

ORGANIZATION AND BASIS OF PRESENTATION	3 Months Ended
	Jun. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND BASIS OF PRESENTATION	(1) ORGANIZATION AND BASIS OF PRESENTATION The accompanying interim condensed consolidated financial statements have been prepared by the Company, without audit, in accordance with the instructions to the Quarterly Report on Form 10-Q, and Rule 10-01 of Regulation S-X promulgated by the United States Securities and Exchange Commission (the “SEC”) and, therefore, do not include all information and footnotes necessary for a fair presentation of its consolidated financial position, results of operations and cash flows in accordance with accounting principles generally accepted in the United States (“GAAP”). In the opinion of management, the unaudited financial information for the interim periods presented reflects all adjustments, consisting of only normal and recurring adjustments, necessary for a fair presentation of the Company’s consolidated financial position, results of operations, and cash flows. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2016. Operating results for interim periods are not necessarily indicative of operating results for an entire fiscal year. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts and the disclosure of contingent amounts in the Company’s financial statements and the accompanying notes. Actual results could materially differ from those estimates. These condensed consolidated unaudited financial statements reflect all adjustments, including normal recurring adjustments which, in the opinion of management, are necessary to present fairly the operations and cash flows for the periods presented. Sundance Strategies, Inc. (formerly known as Java Express, Inc.) was organized under the laws of the State of Nevada on December 14, 2001, and engaged in the retail selling of beverage products to the general public until these endeavors ceased in 2006; it had no material business operations from 2006, until its acquisition of ANEW LIFE, INC. (“ANEW LIFE”), a subsidiary of Sundance Strategies, Inc. (“Sundance Strategies,” the “Company” or “we”). The Company is engaged in the business of purchasing or acquiring and selling life insurance policies and residual interests in or financial products tied to life insurance policies, including notes, drafts, acceptances, open accounts receivable and other obligations representing part or all of the sales price of insurance, life settlements and related insurance contracts being traded in the secondary marketplace, often referred to as the “life settlements market.” Currently, the Company is focused on the purchase and sale of net insurance benefit contracts (“NIBs”) based on life settlements or life insurance policies. The Company does not take possession or control of the policies. The Holder of the life settlements or life insurance policies acquire such policies at a discount to their face value. The Holder has available credit to pay premiums and expenses on the underlying policies until settlement. On settlement, the Company receives the net insurance benefit after all borrowings, interest and expenses have been paid by the Holder out of the settlement proceeds.

NEW ACCOUNTING PRONOUNCEMENTS

NEW ACCOUNTING PRONOUNCEMENTS	3 Months Ended
	Jun. 30, 2016
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
NEW ACCOUNTING PRONOUNCEMENTS	(2) The Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2014-09, 2015-14 and 2016-8, 10,11 and 12 – Revenue from Contracts with Customers, which provides a single, comprehensive revenue recognition model for all contracts with customers. The core principal of the ASUs is that an entity should recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The ASUs also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. In July 2015, the FASB deferred the effective date of this standard. As a result, the standard and related amendments will be effective for the Company for its fiscal year beginning April 1, 2018, including interim periods within that fiscal year. Early application is permitted, but not before the original effective date of April 1, 2017. Entities are allowed to transition to the new standard by either retrospective application or recognizing the cumulative effect. The Company is currently evaluating the guidance, including which transition approach will be applied and the estimated impact it will have on our consolidated financial statements. The Company does not believe adoption of the ASUs will have a material impact on the consolidated financial statements. In August 2014, the FASB issued ASU 2014-15 Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. The new standard provides guidance around management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and to provide related footnote disclosures. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. Early adoption is permitted. The adoption of this standard is not expected to have a material impact on the Company’s financial statements. In January 2016, the FASB issued ASU 2016-01 regarding Financial Instruments, which amended guidance on the classification and measurement of financial instruments. Under the new guidance, entities will be required to measure equity investments that are not consolidated or accounted for under the equity method at fair value with any changes in fair value recorded in net income, unless the entity has elected the new practicability exception. For financial liabilities measured using the fair value option, entities will be required to separately present in other comprehensive income the portion of the changes in fair value attributable to instrument-specific credit risk. Additionally, the guidance amends certain disclosure requirements associated with the fair value of financial instruments. The standard will be effective for the Company’s fiscal year beginning April 1, 2018, including interim reporting periods within that fiscal year. The Company is currently evaluating the effect of the adoption of this guidance on the consolidated financial statements. In February 2016, the FASB issued ASU 2016-02 related to the accounting for leases. This pronouncement requires lessees to record most leases on their balance sheet, while expense recognition on the income statement remains similar to current lease accounting guidance. The guidance also eliminates real estate-specific provisions and modifies certain aspects of lessor accounting. Under the new guidance, lease classification as either a finance lease or an operating lease will determine how lease-related revenue and expense are recognized. The pronouncement is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2018. The Company is currently evaluating the effect of the adoption of this guidance on the consolidated financial statements. In March 2016, the FASB issued ASU 2016-06 related to the embedded derivative analysis for debt instruments with contingent call or put options. This pronouncement clarifies that an exercise contingency does not need to be evaluated to determine whether it relates only to interest rates or credit risk. Instead, the contingent put or call option should be evaluated for possible bifurcation as a derivative in accordance with the four-step decision sequence detailed in FASB ASC 815-15, without regard to the nature of the exercise contingency. The pronouncement is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2016. The Company does not believe the adoption of this guidance will have a material effect on the consolidated financial statements. In March 2016, the FASB issued ASU 2016-09, Improvements to Employee Share-Based Payment Accounting. The new standard is designed to simplify the areas of share based payments relating to income tax consequences. ASU 2016-09 is effective for the Company for its fiscal year beginning April 1, 2017. The Company is currently evaluating the effect of the adoption of this guidance on the consolidated financial statements. In June 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-13, Financial Instruments - Credit Losses. ASU 2016-13 requires entities to report “expected” credit losses on financial instruments and other commitments to extend credit rather than the current “incurred loss” model. These expected credit losses for financial assets held at the reporting date are to be based on historical experience, current conditions, and reasonable and supportable forecasts. This ASU will also require enhanced disclosures relating to significant estimates and judgments used in estimating credit losses, as well as the credit quality. The amendments are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company is currently evaluating the impact the adoption of ASU 2016-13 will have on its consolidated financial statements and results of operations. The Company has reviewed all other recently issued, but not yet adopted, accounting standards, in order to determine their effects, if any, on its results of operations, financial position or cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its financial statements.

ADVANCE FOR INVESTMENT IN NET I

ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS	3 Months Ended
	Jun. 30, 2016
ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS [Abstract]
ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS	(3) ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS On June 7, 2013, the Company entered into an Asset Transfer Agreement (the “Del Mar ATA”) with Del Mar Financial, S.a.r.l. (“Del Mar”). As part of the Del Mar ATA, the Company entered into a Structuring and Consulting Agreement with Europa Settlement Advisors Ltd. (respectively, the “Europa Agreement” and “Europa”). The Del Mar ATA involved the purchase of certain life settlement assets consisting of the legal and net beneficial ownership interest in a portfolio of life insurance policies (the “NIBs”), among other assets that are consideration and collateral for certain cash advances and expense payments made by the Company. According to the Del Mar ATA, Del Mar, with the assistance of Europa, was obligated to convert the NIBs and other newly acquired NIBs into “Qualified NIBS.” As soon as Del Mar met its obligation to provide Qualified NIBs to the Company, any remaining NIBs and any other consideration and collateral would be returned or released to Del Mar. The original due date for the conversion was December 31, 2013, which date was subsequently extended several times. On April 30, 2015, the Company finalized an amendment to the Del Mar ATA and the related Europa Agreement to extend the deadline until August 31, 2015. The remaining consideration and collateral under the Del Mar ATA, as of September 1, 2015, primarily consisted of approximately 72.2% of the NIBs associated with a portfolio of life settlement policies having a face value that originally totaled $94,000,000. The remaining 27.8% interested in the NIBs were held by other parties. During June 2015, one of the life settlement policies matured for $10,000,000 (the “Matured Policy”), lowering the remaining face value of such life settlement policies to $84,000,000. The premiums and expenses related to the maintenance of these life insurance policies are financed by a loan from a lender. As Del Mar was unable to provide the required amount of Qualified NIBs by the extended due date of August 31, 2015, effective September 1, 2015, the agreements with Del Mar and Europa were cancelled and the Company obtained full ownership and control of the collateral, which included the above mentioned approximately 72.2% of the NIBs associated with the $84,000,000 face value of life settlement policies and certain rights to net proceeds relating to the Matured Policy. On September 30, 2015, the Company transferred to Investment in NIBs the remaining balance of advances and expense payments to Del Mar, totaling $3,368,380, which approximates fair value. This amount was residing in advance for investment in NIBs before being transferred to investment in NIBs (see Note 4). The bulk of the $10,000,000 proceeds paid in connection with the Matured Policy were used to repay loans secured by such Matured Policy. However, on September 10, 2015, the Company received $1,094,335 as a result of the rights associated with the Matured Policy. These proceeds were allocated $239,415 to pay off a note receivable (including interest), $547,308 to reimburse the Company for expense payments made to or on behalf of Del Mar and $307,612 as a refund of advance payments previously made to or on behalf of Del Mar as part of the Del Mar ATA. The $547,308 and $307,612 proceeds, which together total $854,920, were applied to reduce Advance for Investment in NIBs. In addition to obtaining full and unrestricted rights to the NIBs upon termination of the Del Mar ATA and Europa Agreement, the Company also is entitled to receive liquidated damages from Del Mar in an amount equal to 100% of any cash advances made under the Del Mar ATA. The Company is currently determining the extent of the liquidated damages claim and Del Mar’s ability to pay any such liquidated damages. The liquidated damages are computed pro rata, based upon the percentage of Qualified NIBs delivered by Del Mar under the Del Mar ATA. The Company received $90,600,000 in Qualified NIBs or approximately 22.65% of the $400,000,000 in Qualified NIBs due under the Del Mar ATA. Accordingly, once 22.65% of its costs and expenses are deducted, the Company would be entitled to receive the remaining amount of its costs and expenses, times two, as liquidated damages. As a result of the termination, the Company has no further payment obligations to Del Mar or fee obligations to Europa.

INVESTMENT IN NET INSURANCE BEN

INVESTMENT IN NET INSURANCE BENEFITS	3 Months Ended
	Jun. 30, 2016
Investments, All Other Investments [Abstract]
INVESTMENT IN NET INSURANCE BENEFITS	(4) INVESTMENT IN NET INSURANCE BENEFITS Investment in NIBs for the three months ended June 30, 2016, and the fiscal year ended March 31, 2016 were as follows: June 30, 2016 March 31, 2016 Beginning Balance $ 29,822,186 $ 22,544,635 Transfers from Advance for Investment in NIBs — 3,368,380 Accretion of interest income 1,453,872 3,909,171 Cash received on accrued interest income (1,417,870 ) — Additional purchases — — Distributions of investments — — Impairment of investments — — Total $ 29,858,188 $ 29,822,186 As explained in Note 3, the Company transferred $3,368,380 from advance for investment in NIBs into investment in NIBs on September 30, 2015. The estimated fair value of the Company’s investment in NIBs approximated carrying value at June 30, 2016, with fair value calculated using level 3 inputs as there is little observable market data available and management is required to use significant judgment in its estimates. During April 2016, the Company received $1,417,870 in cash proceeds associated with the $10,000,000 maturity explained in Note 2 and miscellaneous adjustments to other underlying policies. The cash proceeds had the effect of reducing accrued interest on NIBs. The investment in NIBs is a residual economic beneficial interest in a portfolio of life insurance policies that have been financed by an independent third party via a loan from a senior lender and insured via a mortality risk insurance product or mortality re-insurance (“MRI”). Future expected cash flow is defined as the net insurance proceeds from death benefits after senior debt repayment, mortality risk repayment and service provider or other third-party payments. The Company is not responsible for maintaining premiums or other expenses related to maintaining the underlying life insurance contracts. Therefore, the investment in NIBs balance on the Company’s balance sheet does not increase when premiums or other expenses are paid. The Company holds a 100% interest in the NIBs relating to the underlying life insurance policies as of March 31, 2015. During the year ended March 31, 2016 we acquired NIBs in which the holders of the underlying policies only owned 72%. Therefore, as of June 30, 2016 the Company holds between 72% and 100% in the NIBs relating to the underlying life insurance policies. The Company accounts for its investment in NIBs at the initial investment value increased for interest income and decreased for cash receipts received by the Company. At the time of transfer or purchase of an investment in NIBs, the Company estimates the future expected cash flows and determine the effective interest rate based on these estimated cash flows and our initial investment. Based on this effective interest rate, the Company calculates accretable income, which is recorded as interest income on investment in NIBs in the statement of operations. Our current projections are based off of various assumptions including, but not limited to, the amount and timing of projected net cash receipts, expected maturity events, changes in discount rates, life expectancy estimates and their relation to premiums, interest, and other costs incurred, among other items. These uncertainties and contingencies are difficult to predict and are subject to future events that may impact our estimates and interest income. As a result, actual results could differ significantly from these projections. Therefore, subsequent to the purchase and on a regular basis, these future estimated cash flows are evaluated for changes. If the determination is made that the future estimated cash flows should be significantly adjusted, a revised effective yield is calculated prospectively based on the current amortized cost of the investment, including accrued accretion. Any positive or adverse change in cash flows that does not result in the recognition of an “other-than-temporary impairment” (“OTTI”) results in a prospective increase or decrease in the effective interest rate used to recognize interest income. We have not recognized any significant adverse change in future estimated cash flows relating to our investment in NIBs from our inception in 2013 to the period ended June 30, 2016. During the quarter ended June 30, 2016, and in conjunction with the $1,417,870 cash received in April 2016, the Company received updated information from the policy holders regarding reduced management fees relating to maintaining the underlying policies, and favorable changes in the senior debt balances and related loan-to-value ratios. These changes prompted the Company to reevaluate and make appropriate adjustments to the cash flow models used to calculate accretable income, which resulted in an increase to the effective interest rate used to recognize income on the NIBs. The resulting increase on the Interest Income on Investment in NIBs for the period ending June 30, 2016 was $265,920 over the accretable income that would have been recognized under the prior models. This increase had no significant effect on the Company’s earnings per share.

NOTES PAYABLE AND LINES-OF-CRED

NOTES PAYABLE AND LINES-OF-CREDIT, RELATED PARTY	3 Months Ended
	Jun. 30, 2016
Related Party Transactions [Abstract]
NOTES PAYBALE AND LINES-OF-CREDIT, RELATED PARTY	(5) NOTES PAYABLE AND LINES-OF-CREDIT, RELATED PARTY As of June 30, 2016, the Company had borrowed $3,875,178, excluding accrued interest, from related parties under notes payable and lines-of-credit agreements that allow for borrowings of up to $5,230,000 through the earlier of August 31, 2017, or when the Company completes a successful equity raise, at which time principal and interest is due in full. The notes payable and lines-of-credit incur interest at 7.5%, allow for origination fees and are collateralized by Investment in NIBs. During the three months ended June 30, 2016, the Company borrowed an additional $205,000 under these agreements. The Company also repaid $150,000 during the three months ended June 30, 2016. As of August 9, 2016 the Company can still borrow up to $1,097,322 on these lines-of-credit. The related parties include a person who is the Chairman of the Board of Directors and a stockholder, and Radiant Life, LLC, an entity partially owned by the Chairman of the Board of Directors.

NOTES PAYABLE TRANSFERRED TO RE

NOTES PAYABLE TRANSFERRED TO REDEEMED COMMON STOCK PAYABLE	3 Months Ended
	Jun. 30, 2016
Debt Disclosure [Abstract]
NOTES PAYABLE TRANSFERRED TO REDEEMED COMMON STOCK PAYABLE	(6) NOTES PAYABLE TRANSFERRED TO REDEEMED COMMON STOCK PAYABLE At March 31, 2014, the Company owed $1,455,904, including accrued interest, for notes payable. During the year ended March 31, 2015, the Company had accrued an additional $37,350 in interest. The note incurred interest at 4%, was collateralized by NIBs and was due in April 2015. During June 2015, the note payable and related accrued interest were converted to equity through the issuance of 187,500 shares of common stock and the holder was granted the right to require the Company to redeem the common stock for $8.00 per share. On June 9, 2015, the holder exercised a portion of the redemption right relating to 93,750 shares and, as a result, the Company paid the holder $750,000 to redeem the shares. On March 25, 2016, the holder exercised the redemption right in relation to the remaining shares and on April 12, 2016, the Company paid the holder an additional $750,000 to redeem the remaining shares. At March 31, 2016, the $750,000 associated with the redemption had been classified on the balance sheet as Mandatorily Redeemable Common Stock.

CONVERTIBLE DEBENTURE AGREEMENT

CONVERTIBLE DEBENTURE AGREEMENT	3 Months Ended
	Jun. 30, 2016
CONVERTIBLE DEBENTURE AGREEMENT [Abstract]
CONVERTIBLE DEBENTURE AGREEMENT	(7) CONVERTIBLE DEBENTURE AGREEMENT The Company has entered into an 8% convertible debenture agreement with Satco International, Ltd., that allows for borrowings of up to $3,000,000. The holder originally had the option to convert the outstanding principal and accrued interest to unregistered, restricted common stock of the Company on June 2, 2016. Per the agreement, the number of shares issuable at conversion shall be determined by the quotient obtained by dividing the outstanding principal and accrued and unpaid interest by 90% of the 90 day average closing price of the Company’s common stock from the date the notice of conversion is received; and the price at which the Debenture may be converted will be no lower than $1.00 per share. The original maturity date was June 2, 2016, but was later extended to May 31, 2017. On June 1, 2016, the Company agreed to amend the 8% Convertible Debenture Agreement that extended the due date and conversion rights to August 31, 2017. As of June 30, 2016, the Company owed $700,000 under the agreement, excluding accrued interest. As of August 9, 2016, the Company is still able to borrow up to $2,300,000 on this agreement.

LIQUIDITY AND CAPITAL REQUIREME

LIQUIDITY AND CAPITAL REQUIREMENTS	3 Months Ended
	Jun. 30, 2016
LIQUIDITY AND CAPITAL REQUIREMENTS [Abstract]
LIQUIDITY AND CAPITAL REQUIREMENTS	(8) LIQUIDITY AND CAPITAL REQUIREMENTS Since the Company’s inception on January 31, 2013, its operations have been primarily financed through sales of equity, debt financing, lines of credit from related parties and the issuance of notes payable and convertible debentures. As of June 30, 2016, the Company had $6,254 of cash assets, compared to $24,717 as of March 31, 2016. As of August 9, 2016, the Company has access to draw an additional $1,097,322 on the notes payable and lines-of-credit, related party (see Note 5) and $2,300,000 on the Convertible Debenture Agreement (See Note 7). The Company’s monthly expenses are between approximately $140,000 and $290,000, which includes salaries of our employees, consulting agreements and contract labor, general and administrative expenses and estimated legal and accounting expenses. The Company believes that its existing capital resources, together with the issuance of additional notes payable and convertible debentures and availability under its existing lines of credit with related parties, will be sufficient to fund its operating working capital requirements for at least the next 12 months, or through August 15, 2017. While the Company believes it has sufficient liquidity and capital resources to fund its projected operating requirements through August 15, 2017, it does not anticipate having adequate cash flows from operations for three to four years, and until a revenue stream has been established, it will require debt or equity financing to fund its current and intended business and any future purchases of NIBs. If the Company is unable to raise sufficient capital through the planned securities and debt offerings or other alternative sources of financing, management will curtail NIB purchases. Under this plan, expenditures for NIBs will be curtailed. The accompanying financial statements have been prepared on a going concern basis under which the Company is expected to be able to realize its assets and satisfy its liabilities in the normal course of business. To continue as a going concern beyond the period ended June 30, 2017, and in order to continue to purchase NIBs, the Company will need to raise additional capital to fund operations and purchase NIBs. Absent additional financing, the Company will not have the resources to execute its current business plan and continue operations.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Jun. 30, 2016
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	(9) COMMITMENTS AND CONTINGENCIES As explained in Note 1, the Company is focused on the purchase and sale of NIB’s based on life settlements or life insurance policies. The Company does not take possession or control of the policies. The Holder of the life settlements or life insurance policies acquire such policies at a discount to their face value. The Holder has available credit to pay premiums and expenses on the underlying policies until settlement. On settlement, the Company receives the net insurance benefit after all borrowings, interest and expenses have been paid by the Holder out of the settlement proceeds. However, in the event of default of the Holder, the Company may be required to expend funds on premiums, interest and servicing costs over the next five years to protect its interest in NIBs, though the Company has no legal responsibility nor adequate funds for these payments. In the event that neither party fulfils the financial obligations pertaining to the premiums, interest and servicing costs, the Company would be required to evaluate its investment in NIBs for possible adverse impairment.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	3 Months Ended
	Jun. 30, 2016
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	(10) SUBSEQUENT EVENTS Management has considered subsequent events through August 9, 2016, the date these financial statements were issued. No events have occurred subsequent to June 30, 2016 which would have a material effect on the financial statements of the Company.

INVESTMENT IN NET INSURANCE B16

INVESTMENT IN NET INSURANCE BENEFITS (Tables)	3 Months Ended
	Jun. 30, 2016
Investments, All Other Investments [Abstract]
Summary of Investments in Net Insurance Benefits	Investment in NIBs for the three months ended June 30, 2016, and the fiscal year ended March 31, 2016 were as follows: June 30, 2016 March 31, 2016 Beginning Balance $ 29,822,186 $ 22,544,635 Transfers from Advance for Investment in NIBs — 3,368,380 Accretion of interest income 1,453,872 3,909,171 Cash received on accrued interest income (1,417,870 ) — Additional purchases — — Distributions of investments — — Impairment of investments — — Total $ 29,858,188 $ 29,822,186

ADVANCE FOR INVESTMENT IN NET17

ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS (Narrative) (Details) - USD ($)	Sep. 10, 2015	Jun. 30, 2015	Jun. 30, 2016	Dec. 31, 2014	Sep. 30, 2015	Aug. 31, 2015	May 31, 2015
ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS [Abstract]
Face Value Of Collateral Against Cash Advances					$ 3,368,380	$ 84,000,000	$ 94,000,000
Contracts that matured during the period		$ 10,000,000
Proceeds from matured policy	$ 1,094,335
Proceeds allocated to note receivable payoff	239,415
Proceeds allocated to reimbursement	547,308
Proceeds allocated to refund advance payments	$ 307,612
Proceeds allocated to reduce advance for Investments in NIBs			$ 854,920	$ 904,274
Advance for investments, cash advances, rate			100.00%
Net insurance benefits received			$ 90,600,000
Net insurance benefits, amount received, percentage			22.65%
Net insurance benefits, future amount			$ 400,000,000
Percentage of net insurance benefits associated with a portfolio of life settlement policies having a face value that originally totaled $94,000,000							72.20%
Percentage of net insurance benefits associated with a portfolio of life settlement policies having a face value that originally totaled $94,000,000 held by other parties							27.80%

INVESTMENT IN NET INSURANCE B18

INVESTMENT IN NET INSURANCE BENEFITS (Summary of Investments in Net Insurance Benefits) (Details) - USD ($)	3 Months Ended		12 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Mar. 31, 2016
Investments, All Other Investments [Abstract]
Beginning Balance	$ 29,822,186	$ 22,544,635	$ 22,544,635
Transfers from Advance for Investment in NIBs			3,368,380
Accretion of interest income	1,453,872	$ 824,030	3,909,171
Cash received on accrued interest income	(1,417,870)
Additional purchases
Distributions of investments
Impairment of investments
Total	$ 29,858,188		$ 29,822,186

INVESTMENT IN NET INSURANCE B19

INVESTMENT IN NET INSURANCE BENEFITS (Narrative) (Details)	3 Months Ended
	Jun. 30, 2016USD ($)
Schedule of Investments [Line Items]
Increase in Interest Income on Investment in NIBs as a result of adjustments to the cash flow models used to calculate accretable income	$ 265,920
Minimum [Member]
Schedule of Investments [Line Items]
Ownership Percentage Interest In NIBs	72.00%
Maximum [Member]
Schedule of Investments [Line Items]
Ownership Percentage Interest In NIBs	100.00%

NOTES PAYABLE AND LINES-OF-CR20

NOTES PAYABLE AND LINES-OF-CREDIT, RELATED PARTY (Details) - Stockholder [Member] - USD ($)	3 Months Ended
	Jun. 30, 2016	Aug. 09, 2016
Related Party Transaction [Line Items]
Long-term Line of Credit	$ 3,875,178
Line of Credit Facility, Maximum Borrowing Capacity	$ 5,230,000
Related party note interest rate	7.50%
Proceeds from Lines of Credit	$ 205,000
Repayments of Lines of Credit	$ 150,000
Subsequent Event [Member]
Related Party Transaction [Line Items]
Remaining borrowing capacity		$ 1,097,322

NOTES PAYABLE TRANSFERRED TO 21

NOTES PAYABLE TRANSFERRED TO REDEEMED COMMON STOCK PAYABLE (Details) - USD ($)	Jun. 09, 2015	Apr. 30, 2016	Jun. 30, 2015	Mar. 31, 2015	Jun. 30, 2016	Mar. 31, 2016	Mar. 31, 2014
Debt Instrument [Line Items]
Number of shares repurchased during the period	93,750
Value of shares repurchased during the period	$ 750,000	$ 750,000
Mandatorily Redeemable Common Stock liability						$ 750,000
NIB-Collateralized Note Payable [Member]
Debt Instrument [Line Items]
Notes Payable, including accrued interest							$ 1,455,904
Interest Payable				$ 37,350
Interest rate				4.00%
Maturity date				Apr. 1, 2015
Number of shares issued on conversion			187,500
Repurchase price per share			$ 8

CONVERTIBLE DEBENTURE AGREEME22

CONVERTIBLE DEBENTURE AGREEMENT (Details) - USD ($)	Jun. 02, 2016	Jun. 30, 2016	Aug. 09, 2016	Mar. 31, 2016
Debt Instrument [Line Items]
Convertible Debenture		$ 700,000		$ 700,000
Satco International, Ltd, 8% Convertible Debenture [Member]
Debt Instrument [Line Items]
Interest rate		8.00%
Maturity date	Aug. 31, 2017	Jun. 2, 2016
Convertible Debenture		$ 700,000
Convertible debenture, terms of conversion		Per the agreement, the number of shares issuable at conversion shall be determined by the quotient obtained by dividing the outstanding principal and accrued and unpaid interest by 90% of the 90 day average closing price of the Company's common stock from the date the notice of conversion is received; and the price at which the Debenture may be converted will be no lower than $1.00 per share.
Satco International, Ltd, 8% Convertible Debenture [Member] | Subsequent Event [Member]
Debt Instrument [Line Items]
Remaining amount available to borrow under debt instrument			$ 2,300,000
Satco International, Ltd, 8% Convertible Debenture [Member] | Maximum [Member]
Debt Instrument [Line Items]
Face amount of debt instrument		$ 3,000,000

LIQUIDITY AND CAPITAL REQUIRE23

LIQUIDITY AND CAPITAL REQUIREMENTS (Details) - USD ($)	3 Months Ended
	Jun. 30, 2016	Aug. 09, 2016	Mar. 31, 2016	Jun. 30, 2015	Mar. 31, 2015
Cash and Cash Equivalents	$ 6,254		$ 24,717	$ 21,951	$ 336,370
Subsequent Event [Member] | Stockholder [Member]
Remaining borrowing capacity		$ 1,097,322
Satco International, Ltd, 8% Convertible Debenture [Member] | Subsequent Event [Member]
Remaining amount available to borrow under debt instrument		$ 2,300,000
Minimum [Member]
Monthly expenses incurred by company	140,000
Maximum [Member]
Monthly expenses incurred by company	$ 290,000